Skye Bioscience Inc (SKYE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | SKYE | PRQR | CRDF | ||
Company | Skye Bioscience Inc | Proqr Therapeutics | Cardiff Oncology Inc | ||
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | ||
Open | 12.99 | 1.99 | 3.98 | ||
High | 13.10 | 2.05 | 4.42 | ||
Low | 12.89 | 1.97 | 3.12 | ||
Last | 13.02 | 2.01 | 3.52 | ||
Change | +0.03 | +0.02 | -0.96 | ||
% Change | +0.23% | +1.01% | -21.43% | ||
Volume | 34,800 | 215,600 | 2,160,600 | ||
20-Day Average Volume | 63,975 | 172,105 | 835,705 | ||
Previous Close | 12.99 | 1.99 | 4.48 | ||
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
Has Options | No | Yes | Yes | ||
Technicals | |||||
20-Day Moving Average | 13.46 | 2.05 | 4.68 | ||
20-Day Raw Stochastic | 50.76% | 30.77% | 12.70% | ||
20-Day Relative Strength | 51.23% | 46.78% | 40.54% | ||
Weighted Alpha | -32.26 | +1.23 | +18.24 | ||
Today's Opinion | 72% Buy | 8% Buy | 56% Buy | ||
Previous Opinion | 72% Buy | 8% Buy | 72% Buy | ||
Last Month's Opinion | 80% Buy | 88% Buy | 100% Buy | ||
Performance | |||||
5-Days | |||||
%Chg | +0.15% since 04/26/24 | +3.61% since 04/26/24 | -13.51% since 04/26/24 | ||
Low | 12.52 on 05/01/24 | 1.85 on 05/01/24 | 3.12 on 05/03/24 | ||
High | 13.51 on 04/29/24 | 2.05 on 05/03/24 | 4.68 on 04/29/24 | ||
1-Month | |||||
%Chg | -2.76% since 04/03/24 | -5.41% since 04/03/24 | -33.96% since 04/03/24 | ||
Low | 7.35 on 04/05/24 | 1.81 on 04/18/24 | 3.12 on 05/03/24 | ||
High | 17.65 on 04/18/24 | 2.46 on 04/09/24 | 6.38 on 04/04/24 | ||
3-Month | |||||
%Chg | +225.01% since 02/02/24 | -5.63% since 02/02/24 | +121.38% since 02/02/24 | ||
Low | 4.00 on 02/05/24 | 1.81 on 04/18/24 | 1.44 on 02/05/24 | ||
High | 19.41 on 03/04/24 | 2.70 on 03/15/24 | 6.42 on 03/25/24 | ||
6-Month | |||||
%Chg | +665.88% since 11/03/23 | +66.12% since 11/03/23 | +217.12% since 11/03/23 | ||
Low | 1.44 on 12/01/23 | 1.18 on 11/27/23 | 0.94 on 11/10/23 | ||
High | 19.41 on 03/04/24 | 3.29 on 01/17/24 | 6.42 on 03/25/24 | ||
Key Statistics | |||||
Market Capitalization, $K | 160,784 | 163,524 | 157,379 | ||
Shares Outstanding, K | 12,349 | 81,355 | 44,710 | ||
Annual Sales | 0 | 7,050,000 | 490,000 | ||
Annual Net Income | -37,640,000 | -30,430,000 | -41,440,000 | ||
Last Quarter Sales | 0 | 3,540,000 | 160,000 | ||
Last Quarter Net Income | -4,420,000 | -5,920,000 | -9,340,000 | ||
60-Month Beta | 1.74 | 0.30 | 2.02 | ||
Per-Share Information | |||||
Most Recent Earnings | -3.17 on 11/13/23 | -0.08 on 03/13/24 | -0.21 on 02/29/24 | ||
Latest Earnings Date | 05/09/24 | 05/21/24 | 05/02/24 | ||
Most Recent Dividend | N/A | N/A | N/A | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 0.00 | 0.00 | 0.00 |